In line with these findings, our study supports the concept that DC-based interventions can mitigate aneurysm progression by modulating CD8+ T-cell activation and cytotoxicity and may contribute to restoration of vascular immune homeostasis. The gene discussed is CD8A; the disease is aneurysm.